THE EFFECT OF ZARDAVERINE, AN INHIBITOR OF PHOSPHODIESTERASE ISOENZYME-III AND ISOENZYME-IV, ON ENDOTOXIN-INDUCED AIRWAY CHANGES IN RATS

Citation
Jc. Kips et al., THE EFFECT OF ZARDAVERINE, AN INHIBITOR OF PHOSPHODIESTERASE ISOENZYME-III AND ISOENZYME-IV, ON ENDOTOXIN-INDUCED AIRWAY CHANGES IN RATS, Clinical and experimental allergy, 23(6), 1993, pp. 518-523
Citations number
24
Categorie Soggetti
Allergy,Immunology
ISSN journal
09547894
Volume
23
Issue
6
Year of publication
1993
Pages
518 - 523
Database
ISI
SICI code
0954-7894(1993)23:6<518:TEOZAI>2.0.ZU;2-R
Abstract
Zardaverine is a novel phosphodiesterase III/IV inhibitor, developed a s a potential therapeutic agent for asthma. In this study we evaluated the effect of zardaverine in an in vivo animal model of airway inflam mation and hyperresponsiveness. Endotoxin exposure in rats causes a tr ansient increase in airway responsiveness and a neutrophilic inflammat ion of the bronchi, which are both at least partly mediated through th e secondary release of tumour necrosis factor alpha (TNFalpha). Groups of 10 animals each were pretreated with placebo or zardaverine (1, 10 , 30 mumol/kg) i.p., 30 min prior to exposure to aerosolized endotoxin (LPS) or saline. Ninety minutes later, airway responsiveness to 5-HT was assessed and bronchoalveolar lavage (BAL) performed. Zardaverine d id not influence baseline lung resistance (R(L)), but inhibited dose d ependently the 5-HT induced increase in R(L) in control animals. In pl acebo pretreated animals LPS exposure caused a significant decrease in PC50R(L)5-HT (provocative concentration of 5-HT causing a 50% increas e in R(L)), compared to the saline exposed control group (1.1 +/- 0.1 vs 2.7 +/- 0-4 mug/kg) (P < 0.01). This decrease in PC50R(L)5-HT was s ignificantly inhibited by zardaverine 30 mumol/kg (5.4 +/- 1.8 vs 1.1 +/- 0.1 mug/kg) (P < 0.05). Compared to placebo pre-treated, LPS expos ed animals, zardaverine 30 mumol/kg also significantly inhibited to LP S induced neutrophil increase (193.0 +/- 50.0 vs 915.6 +/- 181.3 x 10( 3)) (P < 0.01), increase in elastase activity (23 +/- 11 vs 54 +/- 9 n mol substrate/h/ml) (P < 0.05) and TNFalpha release in BAL fluid (93.1 +/- 19.5 vs 229.5 +/- 24.8 U/ml BAL fluid) (P < 0.01). These results indicate that zardaverine suppresses the endotoxin induced airway infl ammation and hyperresponsiveness in rats. Protection against the incre ase in responsiveness can be attributed both to inhibition of TNFalpha release and to functional antagonism towards 5-HT induced bronchocons triction.